Hematology Department Subject Leader Name: Xudong Ma Title: Chief Physician Doctoral Tutor and Master Tutor of Fujian Medical University The Department of Hematology has 13 physicians, including 3 chief physicians, 1 deputy chief physician, 4 attending physicians and 5 residents. Hematology specialty is one of the key disciplines of our hospital. Founded in the early 70's, it has 36 authorized beds and is equipped with a hemochemistry room and a blood cell separation room. The ward has been awarded as the advanced department of the city hospital for many times, and won the title of "Youth Civilization" in Zhangzhou City and Fujian Province. There are more than 20 medical and nursing staff, including 9 senior titles. All medical staff adhere to the patient-centered, to provide patients with quality services. In addition to treating patients with hematological diseases in Zhangzhou, it also treats some patients from Anxi, Jinjiang, Nan'an, Longyan and Xiamen, etc. With more than 700 inpatient admissions, more than 7,000 outpatient visits and more than 600 bone marrow examinations annually, it is the hematological disease diagnosis and treatment center in Zhangzhou. In addition to completing a large number of clinical diagnosis and treatment of hematological diseases, the specialty focuses on the research of hematopoietic system malignant tumors--leukemia, myelodysplastic syndrome (MDS) and malignant lymphoma, and has successively accepted and completed scientific research projects in Fujian Province, East China and the whole country, among which, the first to apply all-trans retinoic acid in the province to treat acute Among them, the department has taken the lead in applying all-trans retinoic acid in the treatment of acute promyelocytic leukemia in the province, with an average complete remission rate of 86.7% and a 3-year survival rate of 71.77% after remission, which is up to the advanced level in China; it has also carried out a large number of laboratory and clinical researches on MDS, and has put forward a unique insight into the subtypes of MDS; and it has achieved remarkable therapeutic effects in treating certain refractory immune diseases for which the conventional drug treatments are ineffective, which is at the leading level in the province. Over the years, blood specialist medical staff **** write more than a hundred papers to participate in academic conferences at home and abroad at all levels, of which 31 published in national publications, 37 provincial publications, won the provincial and municipal excellent papers 13; 14 scientific research projects, has been awarded the Fujian Provincial Medical and Health Science and Technology Progress Award 2, Zhangzhou City, Science and Technology Progress Award 5.